Get started
Author

Molly E. Johnson

Observed names: Molly E Johnson, Molly Johnson
ORCID: 0000-0001-9575-3192
Observed ORCID: 0000-0001-9575-3192
OpenAlex ID: A5000614076
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
2018 · Hervé Tiriac, Pascal Belleau, et al. · Cancer Discovery · 1,080
scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution
2021 · Bilge E. Öztürk, Molly E. Johnson, et al. · eLife · 60
Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms
2019 · Kanika Arora, Minita Shah, et al. · Scientific Reports · 58
PDF
Identification of Head and Neck Cancer Subtypes Based on Human Papillomavirus Presence and E2F-Regulated Gene Expression
2018 · Molly E. Johnson, Paul G. Cantalupo, et al. · mSphere · 29
Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants
2022 · Zhouhuan Xi, Bilge E. Öztürk, et al. · Molecular Therapy — Methods & Clinical Development · 19
PDF
Disseminated histoplasmosis in a patient with common variable immunodeficiency: A coincidence or the result of T cell defects?
2017 · Molly E Johnson, Christian Rojas-Moreno, et al. · IDCases · 5
PDF
Structural dynamics insights into principles underlying the fitness of new broadly potent AAVs
2026 · Molly E. Johnson, Bilge E. Ozturk, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Author response: scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution
2021 · Bilge E Öztürk, Molly E Johnson, et al. · eLife · 1
Works count: 8
Citation count: 1,253
H-index: 5
I10-index: 5
Year
Topic
Type